Arnon Krongrad is a surgeon-scientist in South Florida. In 1999, he became the first surgeon to perform laparoscopic radical prostatectomy in the United States, and he coauthored Laparoscopic Radical Prostatectomy: A Technical Monograph, which standardized the operation now performed robotically worldwide. A board-certified urologist, he founded the Krongrad Institute, America's longest-running program devoted to the procedure.

His basic and clinical research has appeared in JAMA and Cancer Research, and he was a coauthor on Larry Clark's landmark selenium trials, among the first to show that a dietary supplement could reduce cancer incidence. His current research centers on metabolic health, including early-stage clinical trials of the peptide Pep19 in adults with obesity, with results published in Diabetes/Metabolism Research and Reviews and forthcoming in iScience.

He earned his BA in chemistry at Columbia College and his MD at the College of Physicians & Surgeons, completed a surgical internship at the University of Hawaii and a urology residency at Mount Sinai Medical Center, and completed a fellowship in endocrinology and metabolism at UT Southwestern Medical Center.

He is a cofounder and chief medical officer of Proteimax Biotechnology, a peptide discovery company focused on metabolic health, and founder of Ezz, a knowledge club devoted to maximum health. He shares updates on LinkedIn and X.